By 2030, 70 percent of HIV patients will be over 50. Now success of HIV drugs poses a new challenge: treating it as a geriatric condition.
Democrat Senator Claire McCaskill on Thursday asked Kaleo Pharmaceuticals to justify the more than 550 percent surge in the price of its device to treat painkiller overdoses, becoming the second senator to question Evzio's $4,500 price tag. Privately held Kaleo has raised the price of a twin-pack to $4,500, from $690 in 2014, according to a Kaiser Health News...
David Gortler, associate professor at Georgetown University, says it is good that people are having conversations on the FDA but drug pricing remains complicated.
Amnesty International accuses Philippines President Rodrigo Duterte of putting killers on police payroll.
Jack Vitayanon, 41, allegedly had been distributing meth for several years and was seen on a video chat smoking the drug in his residence.
Carolin Roth discusses Roche's latest earnings data, and how new U.S. President Donald Trump will affect the pharmaceuticals industry.
Roche CEO Severin Schwan discusses fourth quarter earnings and his business strategy for the company's diabetes segment in the U.S.
Roche CEO Severin Schwan discusses his strategy in the U.S. despite President Donald Trump's protectionism, as well as pricing pressures around the world.
Latin America has warily watched as Trump insisted he would force Mexico to pay for a wall between the United States and Mexico to curb illegal immigration and drug trafficking. "This is a wall that will separate us Latin Americans from the United States because if you affect Mexico you affect Latin America," Ernesto Samper, a former centrist Colombian president,...
The Philippine police chief stopped the use of the national police force in anti-drug operations and disbanded police anti-narcotics units.
Novo Nordisk is investing 115 million pounds in a new research center in Britain, undeterred by Brexit.
JPMorgan presents its favorite drug stock ideas into earnings season.
Stephen Ubl, Pharmaceutical Research and Manufacturers of America (PhRMA) president & CEO, discusses the political rhetoric around the pharma industry and drug pricing.
Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns.
Mexico's most notorious cartel kingpin who spent years on the run as the country's most wanted man, was extradited to the U.S. Thursday.
Jan 17- McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into whether it failed to report suspicious orders of addictive painkillers. Tuesday's deal with the U.S. Justice Department followed an earlier settlement with the company over similar violations in 2008.
Peruvian authorities seized two tons of cocaine in packages that were supposed to contain only asparagus.
Discussing President-elect Trump's comments on the pharmaceutical industry with Bill George, Harvard Business School senior fellow and former Medtronic CEO.
Morgan Stanley's 2020 earnings-per-share estimate for Merck is $5.82 versus the Wall Street consensus of $4.97.
CNBC's Meg Tirrell speaks with Dr. Len Schleifer, Regeneron president & CEO, about industry's viewpoint on patients and drug pricing.